Breast Cancer Diagnostics Market Competitive Landscape, Regional Outlook and Driving Factors Analysis 2019-26 | Hologic Inc., GE Healthcare, Fujifilm Holdings Corporation, Toshiba Corporation, Genomic Health.

MarketStudyReport.com offers 2019 report on Global Breast Cancer Diagnostics Market that evaluates industry growth trends through historical data and estimates prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2019-2026.

Global Breast Cancer Diagnostics Market is valued approximately USD 5.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2020-2026. Breast cancer is a malignant tumor formed in the breast cells that can spread into the whole parts of the body.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/2610785/?utm_source=openpr.com/&utm_medium=VSD

The regional analysis of global Breast Cancer Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high patient awareness, well-established diagnostic infrastructure, and the early adoption of technologically advanced imaging systems in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to rising incidence of breast cancer and rapidly improving healthcare infrastructure in the countries like China and India.

Similarly, as per the European Breast Cancer Coalition, incidence in the EU-28 in 2018 was estimated to be around 404,920. This, in turn, is anticipated to accelerate the demand of breast cancer diagnostics around the world. However, high installation cost of devices and side effects of radiation are the few factors expected to impede the growth of the market over the forecast period of 2020-2026.

According to the World Cancer Research Fund International (WCRFI), breast cancer is the most common form of cancer in women worldwide with an average 2million new cases being detected every year. American Cancer Research Society (ACRS) anticipates by 2030, that incident rate of breast cancer is expected to reach over 9.9 million cases with over 5.5 million annual deaths, primarily due to aging population.

Increasing incidence of breast cancer among women, growing number of approvals for breast cancer diagnosis technologies, and favorable reimbursement framework for breast cancer diagnosis are the few factors responsible for high CAGR of the market over the forecast period.

It is diagnosed with the use of several tests to locate the site of initiation and the spread of the tumor to several parts of the body. At the initial stage, it can be diagnosed through certain screening tests such as yearly mammograms, MRI and CT scan.

Major market player included in this report are:
o Hologic Inc.
o GE Healthcare
o Phillips Healthcare
o Fujifilm Holdings Corporation
o Gamma Medica Inc.
o Toshiba Corporation
o Aurora Imaging Technology Inc.
o Dilion Technologies Inc.
o Genomic Health
o NanoString Technologies, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diagnostic Type:
o Ionizing breast imaging technologies
o Non-ionizing imaging technologies

By End-User:
o Hospitals
o Cancer research centers/institutes
o Diagnostic Clinical laboratories
o Ambulatory Surgical centers

By Region:
o North America
o U.S.
o Canada
o Europe
o UK
o Germany
o Asia Pacific
o China
o India
o Japan
o Latin America
o Brazil
o Mexico
o Rest of the World

Furthermore, years considered for the study are as follows:
o Historical year - 2016, 2017, 2018
o Base year - 2019
o Forecast period - 2020 to 2026

Target Audience of the Global Breast Cancer Diagnostics Market in Market Study:
o Key Consulting Companies & Advisors
o Large, medium-sized, and small enterprises
o Venture capitalists
o Value-Added Resellers (VARs)
o Third-party knowledge providers
o Investment bankers
o Investors

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/2610785/?utm_source=openpr.com/&utm_medium=VSD

Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Breast Cancer Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. Breast Cancer Diagnostics Market, by Diagnostic Type, 2018-2026 (USD Billion)
1.2.3. Breast Cancer Diagnostics Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Breast Cancer Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Breast Cancer Diagnostics Market Dynamics
3.1. Breast Cancer Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Breast Cancer Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry

Related Report:
Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, and cervical cancer, which in turn is a prime factor fostering the demand for topotecan hydrochloride across the globe.

https://www.marketstudyreport.com/reports/topotecan-hydrochloride-market?utm_source=openpr.com/&utm_medium=VSD

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com/
News: https://www.cuereport.com/

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.